Sangwoo Park serves as Executive at NKGen Biotech, Inc., where they oversee executive responsibilities. Since joining the company, Sangwoo Park has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 13, 2023 involved gifting 2,500,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 13, 2023 | NKGN | $0 | Gift | 2,500,000 | $N/A | Discretionary |
Sangwoo Park currently holds 10,120,612 shares of NKGen Biotech, Inc. (NKGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sangwoo Park has been a net neutral trader of NKGN stock. They have purchased $0 and sold $0 worth of shares.
Sangwoo Park's most recent insider trade was on Dec 13, 2023, when they sold 2,500,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted